Naoko Yanagisawa

Dr. Naoko Yanagisawa


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
NYNaoko Yanagisawa
Naoko Yanagisawa
HUHidehiro Ueshiba
Hidehiro Ueshiba
YAYoshihiro Abe
Yoshihiro Abe
HKHidehito Kato
Hidehito Kato
THTomoaki Higuchi
Tomoaki Higuchi
JYJunji Yagi
Junji Yagi
Gut commensal microorganisms have been linked with chronic inflammation at the extra-intestinal niche of the body. The object of the study was to investigate on the chronic effects of a gut commensal Escherichia coli on extra-intestinal glands. The presence of autoimmune response was diagnosed by autoantibody levels and histological methods. Repeated injection of E. coli induced mononuclear cell inflammation in the Harderian and submandibular salivary glands of female C57BL/6 mice. Inflammation was reproduced by adoptive transfer of splenocytes to immune-deficient Rag2 knockout mice and CD4+ T cells to mature T cell-deficient TCRβ-TCRδ knockout mice. MALDI TOF mass spectrometry of the protein to which sera of E. coli-treated mice reacted was determined as the outer membrane protein A (OmpA) of E. coli. Multiple genera of the Enterobacteriaceae possessed OmpA with high amino-acid sequence similarities. Repeated injection of recombinant OmpA reproduced mononuclear cell inflammation of the Harderian and salivary glands in mice and elevation of autoantibodies against Sjögren’s-syndrome-related antigens SSA/Ro and SSB/La. The results indicated the possibility of chronic stimuli from commensal bacteria-originated components as a pathogenic factor to elicit extra-intestinal autoimmunity.

13 February 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
TOToshifumi Osaka
Toshifumi Osaka
YYYoko Yamamoto
Yoko Yamamoto
TSTakehisa Soma
Takehisa Soma
NYNaoko Yanagisawa
Naoko Yanagisawa
SNSatoru Nagata
Satoru Nagata
Severe cases of COVID-19 continue to put pressure on medical operations by prolonging hospitalization, occupying intensive care beds, and forcing medical personnel to undergo harsh labor. The eradication of SARS-CoV-2 through vaccine development has yet to be achieved, mainly due to the appearance of multiple mutant-incorporating strains. The present study explored the utility of human intravenous immunoglobulin (IVIG) preparations in suppressing the aggravation of any COVID-19 infection using a SARS-CoV-2 pseudovirus assay. Our study revealed the existence of IgG antibodies in human IVIG preparations, which recognized the spike protein of SARS-CoV-2. Remarkably, the pretreatment of ACE2/TMPRSS2-expressing host cells (HEK293T cells) with IVIG preparations (10 mg/mL) inhibited approximately 40% entry of SARS-CoV-2 pseudovirus even at extremely low concentrations of IgG (0.16–1.25 mg/mL). In contrast, the antibody-dependent enhancement of viral entry was confirmed when SARS-CoV-2 pseudovirus was treated with some products at an IgG concentration of 10 mg/mL. Our data suggest that IVIG may contribute to therapy for COVID-19, including for cases caused by SARS-CoV-2 variants, since IVIG binds not only to the spike proteins of the virus, but also to human ACE2/TMPRSS2. An even better preventive effect can be expected with blood collected after the start of the COVID-19 pandemic.

25 August 2018 in Suizo
Verified
Journal Article
Closed access
PDF file
NYNaoko Yanagisawa
Naoko Yanagisawa
KSKyoko Shimizu
Kyoko Shimizu
IHIkuko Haruta
Ikuko Haruta
YAYoshihiro Abe
Yoshihiro Abe
THTomoaki Higuchi
Tomoaki Higuchi
JYJunji Yagi
Junji Yagi
自己免疫性膵炎(autoimmune pancreatitis:AIP)type 1の病態に自然免疫と獲得免疫の両者が関与する知見が積み重ねられている.AIPは免疫系感受性遺伝子を背景として何らかの環境因子の関与により発症すると考えられているが,成因の詳細は不明である.環境因子に着目すると,微生物,特に常在細菌が慢性持続的な免疫刺激を担うことによってAIPの成因に関係する可能性が示唆された.そのメカニズムとしては,細菌のパターン認識受容体による自然免疫の活性化,細菌が誘導する炎症性サイトカインによる自己応答性T細胞の活性化,細菌による組織傷害に伴う自己抗原の放出および自己抗原と細菌構成分子との分子擬態などが想定されている.AIPの病態と細菌構成分子の関連性については今後のさらなる研究が必要であるが,細菌学的なAIP診断法あるいは治療法の可能性が期待される.